BACKGROUND: In an attempt to map the genes predisposing to the common, complex aetiologies of end-stage renal disease (ESRD), we performed a genome-wide scan in 1023 individuals with chronic kidney disease (946 dialysis dependent and 77 with advanced chronic renal failure) from 483 African American families. METHODS: The study sample comprised 563 ESRD-affected sibling pairs, with nephropathy attributed to diabetes mellitus, chronic glomerular disease or hypertension. Multipoint non-parametric linkage (NPL) analysis methods were employed. RESULTS: NPL regression provided modest evidence of linkage to 13q33.3 near D13S796 [log of the odds (LOD) = 1.72], 9q34.3 near D9S1826 (LOD = 1.22), 4p15.32 near D4S2639 (LOD = 1.11) and 1q25.1 near D1S1589 (LOD = 1.01). Adjusting for the evidence of linkage at the other loci using NPL regression analysis provided evidence for linkage to 4p15.32, 9q34.3 and 13q33.3. NPL regression interaction and ordered subset analysis (OSA) suggested that the evidence for linkage to ESRD significantly increased with higher body mass index (BMI) at 13q33.3 (LOD = 4.94 in 61% of families with the highest BMI). Additionally, OSA suggested that linkage significantly improved in the 13% of families with earliest age at ESRD onset (LOD = 3.05 at 2q32.1) and in the 16% of families with latest age at ESRD onset (LOD = 2.47 at 10q26.3). CONCLUSIONS: Multipoint single-locus linkage analysis provided modest evidence of linkage to all-cause ESRD in African Americans on 13q33.3, and NPL regression and OSA suggested that evidence for linkage in this region markedly increased in obese families. This region, as well as 9q34.3, 4p15.32 and 1q25.1, should receive priority in the search for loci contributing to ESRD susceptibility in African Americans.
BACKGROUND: In an attempt to map the genes predisposing to the common, complex aetiologies of end-stage renal disease (ESRD), we performed a genome-wide scan in 1023 individuals with chronic kidney disease (946 dialysis dependent and 77 with advanced chronic renal failure) from 483 African American families. METHODS: The study sample comprised 563 ESRD-affected sibling pairs, with nephropathy attributed to diabetes mellitus, chronic glomerular disease or hypertension. Multipoint non-parametric linkage (NPL) analysis methods were employed. RESULTS: NPL regression provided modest evidence of linkage to 13q33.3 near D13S796 [log of the odds (LOD) = 1.72], 9q34.3 near D9S1826 (LOD = 1.22), 4p15.32 near D4S2639 (LOD = 1.11) and 1q25.1 near D1S1589 (LOD = 1.01). Adjusting for the evidence of linkage at the other loci using NPL regression analysis provided evidence for linkage to 4p15.32, 9q34.3 and 13q33.3. NPL regression interaction and ordered subset analysis (OSA) suggested that the evidence for linkage to ESRD significantly increased with higher body mass index (BMI) at 13q33.3 (LOD = 4.94 in 61% of families with the highest BMI). Additionally, OSA suggested that linkage significantly improved in the 13% of families with earliest age at ESRD onset (LOD = 3.05 at 2q32.1) and in the 16% of families with latest age at ESRD onset (LOD = 2.47 at 10q26.3). CONCLUSIONS: Multipoint single-locus linkage analysis provided modest evidence of linkage to all-cause ESRD in African Americans on 13q33.3, and NPL regression and OSA suggested that evidence for linkage in this region markedly increased in obese families. This region, as well as 9q34.3, 4p15.32 and 1q25.1, should receive priority in the search for loci contributing to ESRD susceptibility in African Americans.
Authors: Meredith A Bostrom; Lingyi Lu; Jeff Chou; Pamela J Hicks; Jianzhao Xu; Carl D Langefeld; Donald W Bowden; Barry I Freedman Journal: Hum Genet Date: 2010-06-08 Impact factor: 4.132
Authors: Nedal H Arar; Venkata S Voruganti; Subrata D Nath; Farook Thameem; Richard Bauer; Shelley A Cole; John Blangero; Jean W MacCluer; Anthony G Comuzzie; Hanna E Abboud Journal: Nephrol Dial Transplant Date: 2008-04-28 Impact factor: 5.992
Authors: Madhumathi Rao; Amy K Mottl; Shelley A Cole; Jason G Umans; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Caroline S Fox; Qiong Yang; Adrienne Cupples; Sudha K Iyengar; Steven C Hunt; Thomas A Trikalinos Journal: Nephrol Dial Transplant Date: 2011-05-28 Impact factor: 5.992
Authors: Marcus G Pezzolesi; Jan Skupien; Josyf C Mychaleckyj; James H Warram; Andrzej S Krolewski Journal: Semin Nephrol Date: 2010-03 Impact factor: 5.299
Authors: Amy K Mottl; Suma Vupputuri; Shelley A Cole; Laura Almasy; Harald H H Göring; Vincent P Diego; Sandra Laston; Nora Franceschini; Nawar M Shara; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Jean W MacCluer; Jason G Umans; Kari E North Journal: Kidney Int Date: 2008-08-13 Impact factor: 10.612
Authors: Pamela J Hicks; Jennifer L Staten; Nicholette D Palmer; Carl D Langefeld; Julie T Ziegler; Keith L Keene; Michele M Sale; Donald W Bowden; Barry I Freedman Journal: Am J Nephrol Date: 2008-06-26 Impact factor: 3.754
Authors: Shirng-Wern Tsaih; Marcus G Pezzolesi; Rong Yuan; James H Warram; Andrzej S Krolewski; Ron Korstanje Journal: Kidney Int Date: 2009-11-18 Impact factor: 10.612
Authors: David J Friedman; Matthew E Talbert; Donald W Bowden; Barry I Freedman; Yves Mukanya; Keiichi Enjyoji; Simon C Robson Journal: Diabetes Date: 2008-12-18 Impact factor: 9.461